celecoxib has been researched along with fluorodeoxyglucose f18 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrio, JR; Bookheimer, SY; Ercoli, LM; Huang, SC; Lavretsky, H; Miller, KJ; Phelps, ME; Siddarth, P; Silverman, DH; Small, GW | 1 |
De Weer, S; Debucquoy, A; Devos, E; Haustermans, K; Landuyt, W; Van Den Heuvel, F; Vermaelen, P | 1 |
Kung, HF; Ploessl, K; Zhu, L | 1 |
1 trial(s) available for celecoxib and fluorodeoxyglucose f18
Article | Year |
---|---|
Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Apolipoprotein E4; Celecoxib; Cerebral Cortex; Cognition Disorders; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Pyrazoles; Radiopharmaceuticals; Sulfonamides; Treatment Outcome | 2008 |
2 other study(ies) available for celecoxib and fluorodeoxyglucose f18
Article | Year |
---|---|
18F-FLT and 18F-FDG PET to measure response to radiotherapy combined with celecoxib in two colorectal xenograft models.
Topics: Animals; Celecoxib; Cell Line, Tumor; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice; Positron-Emission Tomography; Pyrazoles; Sulfonamides; Treatment Outcome; Xenograft Model Antitumor Assays | 2009 |
Chemistry. Expanding the scope of fluorine tags for PET imaging.
Topics: Alzheimer Disease; Aniline Compounds; Celecoxib; Ethylene Glycols; Fluorescent Dyes; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fluoxetine; Glucose; Halogenation; Humans; Melanoma; Neoplasms; Patient Selection; Plaque, Amyloid; Positron-Emission Tomography; Pyrazoles; Radiopharmaceuticals; Sulfonamides | 2013 |